Picture of Theratechnologies logo

TH Theratechnologies News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapTurnaround

Brief: Theratechnologies Confirms Issuance Of U.S. Patent Covering The Use Of Tesamorelin In The Treatment Of Individuals Suffering From Nafld/Nash

Oct 13 (Reuters) - Theratechnologies Inc  TH.TO :
    * THERATECHNOLOGIES CONFIRMS ISSUANCE OF U.S. PATENT
COVERING THE
USE OF TESAMORELIN IN THE TREATMENT OF INDIVIDUALS SUFFERING
FROM NAFLD/NASH

Source text for Eikon:  ID:nGNX3SXSry 
Further company coverage:  TH.TO 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Theratechnologies

See all news